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Research Article
Microfluidic platform with four orthogonal
and overlapping gradients for soluble
compound screening in regenerative
medicine research
We present here a screening method based on a microfluidic platform, which can gener-
ate four orthogonal and overlapping concentration gradients of soluble compounds over a
monolayer of cells, in combination with automated and in situ image analysis, for use in
regenerative medicine research. The device includes a square chamber in which cells are
grown, and four independent supply channels along the sides of the chamber, which are
connected through an array of small diffusion channels. Compounds flown through the
supply channels diffuse through diffusion channels into the chamber to create a gradient
over the cell culture area. Further, the chamber is connected to two channels intended for
introduction of cells and in situ staining. In this study, the dimensions of the different
channels were optimized through finite element modeling to yield stable gradients, and
two designs were used with gradients spanning 2.9–2.4 M and 3.4–2.0 M. Next, overlap-
ping gradients were generated using four rhodamine-derived fluorescent dyes, and imaged
using confocal microscopy. Finally, the platform was applied to assess the concentration-
dependent response of an osteoblastic cell line exposed to a hypoxia-mimicking molecule
phenanthroline, using an in situ fluorescent staining assay in combination with image
analysis, applicable to closed microfluidic devices. The on-chip assay yielded results compa-
rable to those observed in conventional culture, where a range of concentrations was tested
in independent microwells. In the future, we intend to use this method to complement
or replace current research approaches in screening soluble compounds for regenerative
medicine, which are often based on one-sample-for-one-experiment principle.
Keywords:
Automated image analysis / Hypoxia / In situ imaging / Orthogonal gradients /
Regenerative medicine / Screening
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 Additional supporting information may be found in the online version of thisarticle at the publisher’s web-site
1 Introduction
As a direct consequence of an emergent ageing population,
the demand for tissue regenerative strategies is increasing.
Correspondence: Dr. Pamela Habibovic, Instructive Biomateri-
als Engineering Lab, MERLN Institute for Technology-Inspired
Regenerative Medicine, Maastricht University, PO Box 616, 6200
MD Maastricht, The Netherlands
E-mail: p.habibovic@maastrichtuniversity.nl
Fax: +31-43-387-5995
Abbreviations: DAPI, 4′,6-diamidino-2-phenylindole; FBS,
fetal bovine serum; FEM, finite element modeling; HF,
hydrogen fluoride; HIF1, hypoxia-inducible factor 1; SAB,
secondary antibody
Although application of autograft material, that is, tissue
transplanted from elsewhere in the body of the patient to
the defect area, is still considered the gold standard for re-
generation of most tissues, this approach is associated with
important drawbacks, such as donor site morbidity, loss of tis-
sue quality with ageing, and most importantly, limited avail-
ability. Therefore, there is an urgent need for regenerative
strategies that do not rely on transplantation of tissue and
that are off-the-shelf available in large quantities, and at low
cost. Stem cell therapy, cell-based and/or growth factor based
tissue-engineered constructs as well as natural and synthetic
biomaterials are investigated in this context [1].
Colour Online: See the article online to view Figs. 1–4 in colour.
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Classically, the search for alternative (releasable) com-
pounds or combinations thereof, for regenerative medicine
applications, is done by a so-called “candidate approach” [2].
In such an approach, a limited number of compounds is
selected based on a rationale and assumptions, followed by
a long and costly path from characterization to biological as-
sessment both in vitro and in vivo (animal models). However,
this approach may lead to omission of potentially good candi-
dates or late apprehension of poor candidates. Furthermore,
such a rational design is limited by the lack of knowledge of
complex signaling networks, not taking into account concen-
tration, synergistic or temporal effects. Finally, studies are
mainly performed on compounds that already have a known
effect [3, 4], making this approach conceptually weak. As a
consequence, methods are sought for that will accelerate and
improve the efficacy of this search by better substantiating
the choices made, and eventually replace the conventional
“candidate approach” by alternative strategies that allow for
increase of throughput.
When attempting to screen concentration-dependent ef-
fects of a bioactive compound or combined effects of different
compounds, one faces the challenge of vastly increasing num-
bers of conditions. For example, screening the individual and
combined effect of only ten compounds at a single concen-
tration would require testing 1023 (210–1) unique conditions.
Including different time points and replicates would increase
this number even further. Although modern library screen-
ing technologies already allow testing of large numbers of
compounds, these normally do not take into account combi-
nations, concentration dependence, and temporal effects. A
model in which all these parameters are embedded would not
only increase the throughput of screening, but would possibly
also enhance in vitro to in vitro data translatability. Microflu-
idics offers a multitude of possibilities to increase throughput
of screening, owing to extensive opportunities for integration,
parallelization and miniaturization [5]. Moreover, it allows tai-
loring of (biological) microenvironments with high fidelity,
closely mimicking the in vivo situation [6]. The biological
microenvironment is of great importance for the fate of the
individual cell, as well as for communication among individ-
ual cells in the 3D environment of a tissue or organ [7–10].
One very attractive capability of microfluidic systems is to
create and control (multiple) gradients of soluble compounds,
which allows testing a range of concentration in a single as-
say, increasing thereby the overall screening throughput. For
example, Atencia et al. successfully created a multigradient
system that was used to study migration of bacteria [11]. Fur-
thermore, microfluidics can offer a multitude of solutions for
biological read-out and can be highly integrated [5, 12]. De-
vices have been developed that can offer complete cell culture,
biological assay and analysis, such as multiple single-cell gene
expression [13], and have shown promising results [14]. How-
ever, these are usually complex devices with integrated valves
and external control systems, which present many technical
challenges.
In the present study, we have developed a screening
method based on microfluidics, to investigate over time the
concentration-dependent and/or combined effects of small
soluble molecules on cells relevant to bone regenerative
strategies. The screening is performed in a (multi)gradient
microfluidic platform capable of generating four orthogonal
and overlapping gradients of soluble molecules over a mono-
layer of adherent cells, in combination with in situ staining
and analysis using automated image analysis. The design of
the microfluidic platform was first elaborated by finite ele-
ment modeling (FEM), and compared to empirical fluores-
cent gradients, as a predictor of gradient generation. Further-
more, a routine was developed to analyze fluorescent images
to retrieve information at the single-cell level in an automated
way. Using a standalone chip holder, which also functions as
an incubator, we performed live imaging and thereby visu-
alized in situ cell interactions with the gradients of overlap-
ping compounds [15]. As a proof of principle, the screening
method was applied to test the effects of phenanthroline, a
small hypoxia-mimicking molecule with direct applications
in regenerative medicine, on the behavior of an osteoblastic
cell line [16].
2 Materials and methods
2.1 Cell culture device
The core of the platform is a microfluidic chip with a square
chamber with 650 m sides and a height of 75 m, in which
cells are cultured (Fig. 1A). The gradients are generated via
diffusion by supplying compounds through four supply chan-
nels (75 m high × 160 m wide) surrounding the culture
chamber. These supply channels are connected to the cul-
ture chamber through arrays of smaller diffusion channels
(0.5–1 m high × 2–3 m wide × 10 m long, each 4 m
apart, Fig. 1 Insets). By flowing different compounds through
these four supply channels at equal pressure and flow rate,
and due to the high relative resistance between the chamber
and supply channels, the compounds enter the chamber pri-
marily by diffusion. Each supply channel acts as a source of
one compound as well as a sink for compounds from each of
the other supply channels. Therefore, overlapping gradients
of the four compounds are generated inside the chamber. The
gradient can be tuned by changing the size of the channels
connecting the main chamber to the supply channels. Two
channels (75 m high × 160 m wide) that directly connect
to the chamber are meant for inserting, collecting, and in situ
staining of cells.
2.2 Fabrication
The chip was fabricated in thin glass substrates (0.21 mm
D263, Schott, Germany) using a two-step wet-etching process.
Masks were designed using CleWin (WieWeb, The Nether-
lands), and fabricated in-house on 5′ ′ soda-lime glass sub-
strates with chromium masking layer using laser lithography
(DWL2000, Heidelberg Instruments, Germany). In the first
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Figure 1. (A) Schematic isometric representation of the four-gradient microfluidic platform, with the four supply channels (75 m ×
160 m) connected to the chamber (650 m × 650 m) by channel arrays (0.5 m × 2 m × 10 m). Arrows in the supply channels depict
the direction of the flow, and the arrows inside the chamber depict the direction of the gradients. The top inset shows an enlargement of
a channel array. (B) Photograph of the 2 cm × 2 cm die, depicting the via holes, channels, and chamber in the middle. The middle inset
is an enlargement of a fabricated channel array and the bottom inset shows brightfield microscopy image of the fabricated chamber.
etch step, all shallow features with a depth of 0.5–1 m were
realized (masking layer: 50 nm sputtered chromium; etchant:
buffered hydrogen fluoride (HF, etch rate of 60 nm/min;
BASF, Germany). An etching time of 16.5 min resulted in a
channel depth of approximately 1 m, and a width of 3 m.
In the second step, the chamber and the surrounding sup-
ply channels were created, also using standard wet etching
(masking layer: 15 nm sputtered chromium and 200 nm gold;
etchant: 10% HF (BASF) with an etch rate of approximately
1 m/min). Since HF is not buffered, etch rates are un-
predictable and decline in time. Therefore, the etching was
performed in several steps and the height of the structures
measured after each step using a profilometer (DEKTAK,
USA), until a depth of 75 m was reached. In the top glass
substrate (1.1 mm D263), via holes were powder blasted, us-
ing 29 m alumina particles. Finally, both glass substrates
were thermally bonded in an oven (6 h ramp up, 1 h at 570°C,
6 h ramp down). After bonding, the wafers were cut in 2 cm ×
2 cm dies with a dicing saw (DAD 321, Disco, Japan) followed
by polishing (Fig. 1B).
2.3 Complete setup
For cell culture experiments, the microfluidic device is
inserted in an in-house designed and built standalone chip
holder, which provides fluidic connections as well as physi-
ological conditions (37°C, 5% CO2 supplemented air). Since
the glass device is entirely closed, and not gas permeable, gas
exchange is provided by gas-permeable perfluoralkoxy inlet
tubing (150 m id and 360 m od paraformaldehyde HP
Plus, DuPont, USA) inside the chip holder. The ability to use
gas impermeable materials, using this chip holder, keeps the
option to study interactions of cells with biomaterials relevant
in the field of regenerative medicine, which are generally not
gas permeable [15]. The whole platform has the footprint of a
microtiter plate and acts as an incubator, allowing the use of a
variety of standard equipment for in situ measurement. More
details on the standalone chip holder including evidence
that, under normal oxygen tension, cells inside the chip are
not in a hypoxic state, can be found in previously published
work [15].
2.4 Finite element modeling
To predict the gradient conditions and aid the design of
the gradient platform, FEM was used (COMSOL-MEMS,
USA). For the flow, the Navier–Stokes differential was used,
with the assumptions of: (i) incompressible flow, since
liquids in the applicable pressure range have negligible
compressibility; (ii) laminar flow, due to the low flow rates
and channel dimensions (Re  1); and (iii) Stokes flow
whereby inertial terms can be neglected, resulting in:
∇ · [pI +  (∇u + (∇u) )] + F = 0 ∪ ∇ · u = 0, (1)
with pressure p, dynamic viscosity , velocity vector u, the
applied force F, and density  . This was then coupled to
transport of diluted species, convection, and diffusion, with
the assumptions of: (i) neglecting molecular crowding; and
(ii) concentration effects, since low concentrations are used
with respect to the bulk (ci  1M):
∇ · (−Di∇Ci ) + u · ∇Ci = Ri ∪ Ni = −Di∇Ci + uci , (2)
with diffusion coefficient D, species concentration ci, velocity
vector u, species source Ri, species flux Ni, and species num-
ber i. Models with different dimensions were run to optimize
the design. The resulting designs were modeled with different
parameters and subsequently compared to the experimental
results obtained with fluorescent dyes on the final designs to
verify and use the model for gradient prediction. Experimen-
tally, four different fluorescent dyes were used to demonstrate
C© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
478 B. Harink et al. Electrophoresis 2015, 36, 475–484
Figure 2. (A) Graph depicting the comparison of an FEM model gradient with a fluorescent experimental gradient, using a chip with
3 m × 1 m × 10 m diffusion channels. The modeled data (dotted red line) was obtained by finite element analysis and using a
parameters for 10 M solution of rhodamine 6G at a speed of 12 L/h [17]. The experimental data (solid blue line) were obtained the
same conditions, using CE488 fluorescent dye. The line profile was taken from a confocal microscopy image (NIKON Ti-Eclipse with A1
Confocal, Japan), which was taken at a height of 35 m from the bottom of the device (dotted black line in (B)). Since the concentration
in the supply channel is known (right peak), and the dye has approximately linear fluorescence emission to concentration in the range of
10 M and below, this peak was normalized to the modeled data. (B) 3D modeled FEM plot of a single gradient starting from the bottom,
using the same parameters. Colored lines represent concentration iso-lines. (C) Right to left confocal line scan of the same chamber
(horizontal), depicting generated overlapping fluorescent gradients (red, green, and yellow). (D) Confocal 3D volume scan image with all
four gradients overlapped.
the ability to simultaneously generate four overlapping gra-
dients. These dyes are derivatives of rhodamine (CF Dyes,
Sigma) excited at four different excitation wavelengths (405,
488, 543, and 633 nm), specifically selected for the laser lines
of the laser scanning confocal microscope (NIKON Ti-Eclipse
with A1 Confocal, Japan). All final concentrations were 10 M
in DI water (Milli-Q, Millipore), and each solution was flown
through one of the supply channels of the chip at a flow rate
of 12 L/h. For FEM, the diffusion constant of rhodamine 6G
(D = 400 m/s) was used [17]. Both FEM and experiments
with dyes were performed at 37°C and 1 atm. The dimen-
sions of the diffusion channels used were 3 m width ×
1 m height (3 m2), and a length of 10 m. Using confocal
microscopy, scans were taken at half-height of the chamber
(35 m) and compared to the FEM data at the same flow
speed, concentration, and position (Fig. 2). The shape of the
gradient was compared by matching the maximum excita-
tion of the known concentration in the confocal scan with the
maximum in the model.
2.5 Cell culture
Human osteoblast-like MG63 cells were expanded and cul-
tured in alpha minimal essential medium (MEM 41061–
029, Gibco) supplemented with 10% fetal bovine serum (FBS,
Gibco), 100 mg/mL penicillin, and 100 mg/mL streptomycin
(Pen/Strep, Gibco). To determine the concentration range of
interest, and to optimize the imaging analysis, MG-63 cells
were first cultured in conventional well plates. Therefore, cells
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were dissociated from the culture flask using 0.05% trypsin
(Trypsin-EDTA, Gibco), seeded in a 96-well microtiter plate
at a density of 3000 cells/cm2, and left to attach and prolif-
erate using normal culture medium. For experiments in the
microfluidic device, MG63 cells were dissociated in the same
way, and resuspended to a concentration of approximately
5 million cells/mL. This high concentration of cells was re-
quired to ensure sufficient seeding efficiency inside the mi-
crofluidic chamber, since due to the dominant surface forces
in microfluidics, the cell concentration drops dramatically be-
cause the cells tend to concentrate along a single line in the
middle of the microchannels. Prior to injection of the cells, the
glass chip was cleaned and oxidized using piranha solution
(3:1, 100% H2SO4 and 30% H2O2, Sigma-Aldrich) and subse-
quently coated with FBS for at least 2 h. The cell suspension
was injected into the device via the cell loading channel into
the chamber, using a 250 L glass syringe. The final den-
sity inside the chamber was approximately 4500 cells/cm2.
Thereafter, the inlet and outlet of the chip were closed using
shut-off valves to prevent advection during the experiment.
The cells were left to attach for 24 h, while flowing cell culture
medium through the side channels at a flow rate of 8 L/h,
using four 500 L syringes and a single precision syringe
pump (Nexus Performance, Chemyx, USA).
2.5.1 Experiments with phenanthroline, a
hypoxia-mimicking small molecule
To test the cell response to hypoxia in the 96-well mi-
crotiter plate, after 48 h of regular culture, normal cell
culture medium was replaced by culture medium sup-
plemented with different concentrations of phenanthroline
(1,10-phenanthroline monohydrate, Sigma-Aldrich), ranging
from 1.5 to 10 M, prepared from a 1 mM solution in
methanol (Sigma-Aldrich). The concentration was comple-
mented with a negative, positive (100 M), and secondary
antibody (SAB) control, by leaving out the primary antibody.
In the on-chip experiments, normal cell culture medium in
the syringes was replaced after 24 h by medium with re-
duced serum concentration (1% FBS) for a period of 24 h
to arrest the cell proliferation cycle, with the rationale to im-
prove and equalize response and reduce expression differ-
ences among cells, since the number of cells in the chip was
much lower than that in the wells of the microtiter plate.
After 24 h in normal and 24 h in serum-reduced medium,
reduced serum medium supplemented with 10 M phenan-
throline was added in one syringe to create a gradient from
2.9 to 2.3 M inside the chamber (using a chip with diffusion
channels of 2 m width × 0.5 m height × 10 m length,
predicted with FEM modeling: Dphenanthroline = 620 m2/s;
Q = 12 L/h; C = 10 M) [18]. This concentration range
was selected for being at the beginning of the slope of the
S-curve (shape of a sigmoid function) where concentration-
dependent effects of phenanthroline were observed in the
experiment in the well plate (Fig. 3D).
2.5.2 Cell staining and imaging
After 24 h of exposure to phenanthroline in either the chip or
in the well plate, cell culture was stopped and cells were fixed
and stained. On chip, first, the chamber was flushed through
the access channels with PBS (Invitrogen), using a syringe,
to remove medium. Subsequently, a 4% paraformaldehyde
solution was added for 10 min to fix the cells, after which the
cells were permeabilized with 0.1 w/v% Triton-X for 4 min at
37°C. Following this, cells were stained with primary antibody
Mouse anti-Human Anti-HIF1 (Abcam) to locate hypoxia-
inducible factor 1 (HIF1), which stains the alpha subunit
of HIF1, for 2 h at 37°C; and SAB Goat anti-Mouse IgG—
Alexa Fluor 488 to stain the located HIF1, for 1 h at 37°C. In
addition, 4′,6-diamidino-2-phenylindole (DAPI, Sigma) coun-
terstain was used to stain the nuclei of the cells. Image ac-
quisition was performed using an automated plate-reading
fluorescence microscope (BD Pathway 435, BD Biosciences,
USA).
2.6 Image analysis
To analyze the results, high-content screening and image
recognition was used to locate the nucleus of each cell based
on DAPI stain, with high-content imaging software (CellPro-
filer, Broad Institute, USA). The localized and outlined nuclei
were used as overlay on the HIF1 images (Fig. 3B and C),
and the average fluorescent intensity in the nuclei area was
measured. The transcription factor HIF1 translocates into the
nucleus when the hypoxia pathway is induced. This translo-
cation is visible and measurable as a fluorescence intensity
change of the HIF1 stain in the nucleus. By measuring the
mean fluorescent intensity of each individual cell nucleus, the
level of translocation was determined for each concentration
of phenanthroline. In the case of the on-chip experiments, the
nuclei stain was also used for normalizing the fluorescence
intensity of the HIF1 stain to reduce focal plane effects.
Graphs and statistics on the resulting data were performed
using a statistical software package (SPSS, IBM, USA), and
relevant tests were performed as described in Section 3.
3 Results and discussion
In this study, we present a method to screen temporal inter-
actions of adherent cells with (eventually multiple) soluble
compounds by developing a closed microfluidic platform ca-
pable of creating up to four orthogonal and overlapping gradi-
ents of compounds in the solution over a cell monolayer. The
platform, which is designed for application in regenerative
medicine research, is built from glass to allow introduction
of relevant biomaterials into the system in the future. The
microfluidic platform was inserted into a stand-alone chip
holder for cell culture outside the incubator and for time-
lapse or real-time imaging of cell behavior. FEM was used
to aid generation of the desired microenvironment and the
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Figure 3. (A) Close-ups of fluorescent
microscopy images taken from each of
the concentration steps from the mi-
crotiter plate experiment. (B) Image anal-
ysis of cells treated with 10 M phenan-
throline, as an example, where the DAPI
stain was used to visualize the nuclei,
with surrounding lines depicting how
the location of nuclei was determined
(green). (C) HIF1 stain image of the
same area with the overlay of the lo-
cated nuclei, allowing for determination
of the mean fluorescence intensity of
the nuclei, and therefore the level of
translocation. (D) Graph depicting the
relative fluorescent intensity, normalized
to the negative control, in arbitrary units
(AU), inside the nuclei of the HIF1 stain-
ing as response to different concentra-
tions of phenanthroline, including nega-
tive (0 M), positive (100 M), and sec-
ondary antibody (SAB) control.
proof of concept was provided by an experiment showing the
response of osteoblastic cells to a small molecule that mimics
hypoxia.
3.1 Fabrication
When designing platforms in which a chemical microen-
vironment is to be generated with high fidelity, the choice
of materials and fabrication methods is of great impor-
tance. To ensure stability and prevent deformation, and
consequently advection, rigid materials are preferred over
elastomeric materials such as PDMS, which is widely used in
microfluidics [19]. Elastomeric materials present important
limitations in this regard because of their relatively porous
nature [20]. Finally, the platform should be amenable to
further chemical modification to introduce biomaterials
of interest, which, in general, are not gas permeable. The
material of choice for the presented platform was therefore
glass, which is chemically stable and inert, better character-
ized in cell culture systems than PDMS, and applicable for
high-resolution fabrication [21]. A major issue when using
glass, however, is the processing, which is mostly based on
wet etching that is associated with low lateral etch control.
Dry etching is also possible, however, this is a slow process
(1 m/min) that requires harsh and complex masking
techniques. Furthermore, it requires working with more
expensive materials such as quartz or fused silica to ensure
the final surface is smooth, which in turn brings about other
processing limitations. Therefore, we developed a two-step
wet-etching process for common float glass, to produce
both shallow nanometer size features (1 m) and deeper
micrometer size features (50 m), in which we dealt with
the adhesion challenges by using better controlled low etch
rate solutions (hence, prolonged chemical exposure) for small
features.
Conventionally, wet etching of glass uses HF, and a
masking layer of 200 nm gold, together with a 10–15 nm
chromium adhesion layer. For features larger than 10 m,
this method is usually adequate, but combining features
smaller than 10 m with submicron features, as in the plat-
form presented here, required a modified method. First of
all, the small-sized diffusion channels possess a very small
surface area compared to the end feature size, making adhe-
sion of the masking material to the substrate a challenge.
One way to improve adhesion is to reduce the thickness
of the gold layer, making it less top-heavy and smaller in
comparison to the feature. However, this approach would
increase the chance of introducing pinholes caused by im-
perfections in the sputtering of gold. An alternative is to use
a relatively thick chromium layer for masking. Since very
“thick” chromium layers introduce stress, the thickness was
optimized to 50 nm, as the best balance between adhesion,
low-stress and sufficient masking. To control the etch rate,
buffered HF was used, rather than HF, resulting in an etch
rate of approximately 60 nm/min.
3.2 Finite element modeling
FEM was used for determining the design dimensions, and
predicting the gradients to be generated. Generation of more
than two overlapping orthogonal gradients is only possible by
applying a solely diffusion-based gradient generator [22], and
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not by other approaches such as the flow-based T-cell [23] or
mixing-based devices [24]. In the current study, to ensure that
diffusion is the dominant force of compound influx into the
chamber from the supply channels, three conditions had to be
taken into consideration: (i) matching flow conditions in all
four supply channels to prevent pressure gradients over the
chamber, and therefore advection; (ii) creating high relative
resistance between the supply channels and the chamber to
minimize the influence of flow disturbances and restrict ad-
vection even further; and (iii) low Reynolds number to ensure
laminar flow, thus excluding lateral flow.
To match flow conditions in different flow channels as
closely as possible, a single high precision pump with multi-
ple syringes was used, ensuring that any remaining pulsatile
flow and other disturbances were comparable in all syringes.
To achieve high relative resistance, the cell culture chamber
was connected to the supply channels through an array of
smaller diffusion channels in the submicron range. An ap-
proximation of the resistance (Rh) in a rectangular channel is






)∀h  w ∧ Re  2000, (3)
given the conditions that the width (w) is larger than the
height (h) and the Reynolds (Re) number much lower
than 2000. For instance, the resistance in a 50 m ×
100 m × 1 mm channel is approximately 1.4 × 106 Pa·s·m−3
per micrometer and in a 0.5 m × 1 m × 1 mm channel
is approximately 1.4 × 1014 Pa·s·m−3 per micrometer, using
a dynamic viscosity () of 1.0 mPa·s for water, thus an eight
order of magnitude difference, which ensures that the bulk
of the flow passes through the supply channel and not into
the chamber. Furthermore, it was important to reach a com-
promise between the dimensions of the diffusion channels
and the flow stability, which could be affected by mechanical
disturbances from the pump or moving of tubing. With larger
channels, steeper gradients could be achieved, however, the
flow stability was affected/degraded. Analogously, smaller
channels improved the flow stability, but they were limited to
the generation of shallower gradients. Low Reynolds number
can be obtained by using a syringe pump with high-resolution
stepper motor, such that stable low flow rates can be achieved,
well within the laminar flow range (±10 L/h).
Although the gradients are generated by diffusion, the
diffusion coefficient of the compound in the solution does
not have an influence on the final steady state shape of
the generated gradient. It does, however, influence the time
required to reach the equilibrium, which is approximately
10 min for rhodamine-like molecules (MW 479), as observed
by FEM and fluorescent microscopy. Similarly, the initial con-
centration of the compound does not influence the shape of
the gradient either, as long as it is diluted enough with respect
to the solvent. The flow rate has a minor impact on the shape,
provided that it remains well within the laminar flow regime,
and well above the diffusion rate. Therefore, in the design
on the platform presented here, the only parameters that had
a significant influence on the generated gradients were the
cross-section (width × height) and length of the diffusion
channels. Since we have selected and fixed the length of the
channels, the only parameter we varied was the area of the
channel. With a channel area of 0.9 m2 (semispherical chan-
nel of 0.5 m × 2 m), a gradient of 2.9–2.3 M (using 10 M
solution) was achieved, and increasing the channel area size
to 2.6 m2 (semispherical channel of 1 m × 3 m) resulted
in a steeper gradient of 3.4–2.0 M. Thus, by increasing the
area of the channel by 100%, the concentration range, and
therefore the steepness, could be increased by ca. 80%.
The FEM model and the experiment with fluorescent
dyes, in which the channel size of 1 m × 3 m was selected
(Fig. 2A), indicated that the modeled gradient overlaps with
the experimental fluorescent gradient. Therefore, the model
is valid for predicting the generation of the gradient and the
concentration of the compound can be correlated to the dis-
tance from the source of the gradient. As stated before, this
specific device gives a gradient ranging from approximately
3.4 to 2.0 M at a flow rate of 12 L/h. Figure 2C shows
a confocal line scan, taken through the middle of the chip,
from left to right, at half the height of the chamber (see
line, Fig. 2D). Figure 2D shows 3D (z-stack) confocal image
depicting four overlapping gradients generated simultane-
ously. A stability test performed over a period of 24 h, while
controlling the temperature within a ±0.05°C range (major
contributor to diffusion speed change) [15], indicated stable
gradients with variations in concentration 4% (see Support-
ing Information).
3.3 Hypoxia mimicking
As a first proof of concept to show the applicability of this
platform in regenerative medicine research, we have investi-
gated the concentration-dependent effects of phenanthroline,
a compound previously shown to positively affect angiogen-
esis, i.e. new blood vessel formation [16], a process that is
of great relevance for regeneration of most tissues and or-
gans. In the present study, the effect of this compound was
tested on MG63 osteoblastic cell line in the microfluidic gra-
dient platform, and compared to the conventional cell culture
conditions. Vascularization is of crucial importance in bone
regenerative strategies, in particular for treatment of large
bone defects [25]. Phenanthroline is a small molecule from
the LOPAC library (Sigma) that was proposed as a relatively
inexpensive and stable alternative to growth factors such as
vascular endothelial growth factor (VEGF), in stimulating an-
giogenesis. Phenanthroline has been shown to induce HIF1
expression in a dose-dependent manner. HIF1 is a transcrip-
tion factor expressed by mammalian cells when they are in
a hypoxic (low oxygen) state. It plays an essential role in
the systemic response to hypoxia and the release of angio-
genic factors, including VEGF [26]. When hypoxia is induced
in mammalian cells, HIF1 translocates from the cytoplasm
to the nucleus (see Supporting Information for an exam-
ple), which can be visualized by HIF1 immunostaining. For
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Figure 4. DAPI and HIF1 stain images
and analysis in the microfluidic device af-
ter 24 h of exposure to a phenanthroline
gradient of 2.9–2.3 M (the arrows de-
pict the direction of gradient. (A–C) top
and (D–F) bottom of the chamber. (F) In-
sets show zoom in at different concentra-
tions, where differences in intensity were
measured.
the present screen, we have used HIF1 immunostaining,
a subunit of HIF1, followed by quantification of the level of
translocation in each cell, by employing high-content screen-
ing based on imaging algorithms and demonstrated that this
can be a powerful in situ assay, which can be used in closed
microfluidic systems, in which generally, a limited number
of cells is used.
3.3.1 Concentration-dependent effects of
phenanthroline on MG63 cells in conventional
tissue culture
MG63 cells cultured in 96-well plate were treated with
phenanthroline in concentrations ranging from 1.5 to 10 M
for 24 h, in duplicates. A 3 × 3 montage fluorescent im-
age was taken at 200× magnification for each condition.
Figure 3A displays a zoom in of these images. By plotting
the mean fluorescence intensity of the nuclei over the con-
centration, a concentration-dependent effect was observed in
the 2.5–10 M range (Fig. 3D). All tested concentrations in
the 2.5–100 M range differed significantly from each other
and the rest (p  0.05). Only the experiments at 0, 1.5, and
2.0 M and the SAB control did not show statistically differ-
ent levels of translocation. These results translate in a dose-
dependent S-curve response to phenanthroline in the range
of 2.5–10 M. At concentrations of 100 M and higher, the
compound becomes cytotoxic and more cell death was ob-
served (Fig. 3D), which could explain the reduction in average
fluorescence intensity in the nuclei.
3.3.2 Effect of a microfluidic gradient of
phenanthroline on MG63 cells
Following the proof-of-principle experiments in microtiter
plates, a phenanthroline gradient was generated in the mi-
crofluidic platform, using the steep part of the S-curve in
the dose response of phenanthroline. Accordingly, the chip
with diffusion channels of 0.5 m × 1 m was used. After
24 h exposure of MG63 cells to a phenanthroline gradient
(2.9–2.3 M, from left to right, Fig. 4), the culture was
stopped, and DAPI and HIF1 staining was performed. We
observed that cells attached to both the bottom and the top
of the chip, which is probably due to the fact that in a 3D
microfluidic environment, cells experience more forces from
the walls, while the effect of gravity is negligible. Further-
more, such a confined environment is more favorable for the
formation of multilayers than it is the case in a well plate.
For this reason, images were taken from both the bottom and
top of the chamber. Furthermore, to avoid imaging difficul-
ties, only nonoverlapping cells were selected for the analysis,
making the number of cells selected for the analysis lower
than the total number of cells in the chip. Figure 4 shows the
resulting images after staining of cells upon exposure to the
microfluidic gradient—Fig. 4A–C, the top and Fig. 4D–F, the
bottom of the chip. By applying a threshold of the intensity of
the nucleus stain (Fig. 4A and D), the nuclei out of the focal
plane of that layer were discarded, resulting in only located
nuclei in focus (Fig. 4B and E). Further selection discarded
the nuclei that were in a too close proximity to one another,
out of focus, too large, too small, or on the edge of the image.
From the image analysis, the remaining mean intensity
values of the HIF1 stain in each cell nucleus were measured.
This intensity was normalized for the nucleus stain intensity
to correct for focal differences between cells. All values 50 m
from the rim of the chamber (see dotted line Fig. 4C and
F) were used for further analysis, and outliers were removed
(2.5 × SD, five values removed), leaving N = 119 cells. The val-
ues were then placed in a scatter plot for visualization (Fig. 5).
Statistical analysis of these data showed that increasing dis-
tance from the gradient source, thus decreasing concentra-
tion of phenanthroline, had a moderate negative two-tailed
correlation (r = −0.237, p  0.01) with normalized HIF1
fluorescent stain intensity, and linear regression (thick
line = regression line, dotted line = 95% confidence interval,
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Figure 5. Scatter plot depicting the DAPI stain compensated
mean fluorescence intensity of HIF1 stain in the nucleus of
each cell, related to the distance from the gradient source.
The thick line is the regression line with a moderate nega-
tive correlation (r = −0.237, p < 0.01) and significant neg-
ative relationship (N = 119, R2 = 0.056, F(1,117) = 6.957,
p < 0.01). The dotted line depicts the 95% confidence interval.
Fig. 5 demonstrated a significant negative relationship (R2 =
0.056, F(1,117) = 6.957, p  0.01)). Although the number of
cells is low compared to the conventional culture, and each
cell is an experiment instead of treating the whole culture
as an experiment, these results indicated that differences in
response could be detected in a relatively shallow diffusive
gradient of 2.9–2.3 M in the microfluidic chip.
4 Concluding remarks
In the current study, we have undertaken a first step to-
ward screening of soluble compounds in a concentration-
dependent manner for the field of regenerative medicine,
by developing a platform that allows testing of up to four
independent soluble species in a single experiment. While in
this first step, we have provided the proof of concept of our de-
vice by testing the biological effect of one compound only, we
have validated the possibility to simultaneously generate four
identical but orthogonal gradients in a single device, using
fluorescent dyes. In the presented device, the gradient was
relatively shallow, which precludes the study of compounds
in which subtle concentration differences are effective, and
which obviously still limits the analysis throughput if a large
range of concentrations needs to be assessed. We are cur-
rently working on a second-generation device, exhibiting a
wider concentration gradient. Nevertheless, a serial dilution
approach or comparable systems may be more appropriate
for initial screenings before a gradient-based platform as pre-
sented here is used to study any combined effects of various
compounds. On other aspects, the number of cells in one
cell culture chamber was too small in the presented exper-
iments to yield enough statistically relevant data, and this
issue will become even more critical when more than one
compound is simultaneously tested, whereby very few cells
will be exposed to a unique combination. In the future, this
limitation can be addressed by using several identical cham-
bers in parallel, which are run under the same experimen-
tal conditions. Finally, another aspect requiring additional
attention in the future is the possible existence of “side ef-
fects” of having a gradient over a monolayer of cells, such
as polarization, chemotaxis, or directional growth of cells.
In addition to the microfluidic platform, this study was also
aimed at developing an accompanying in situ image anal-
ysis method that allows time-lapse or real-time imaging of
cell behavior upon exposure to soluble compounds. In an
initial experiment conducted in a microtiter plate format, a
routine was developed based on image analysis of nuclei and
HIF1 staining to study concentration-dependent responses
of mammalian cells to phenanthroline exposure. In a sub-
sequent experiment, a comparable image analysis was per-
formed in the microfluidic platform where a shallow gradi-
ent of phenanthroline was created, enabling testing of a given
range of concentration in a single experiment. This second
experiment demonstrated that the proposed method can also
be used to detect dose–response differences inside a shallow
diffusive gradient, while retaining the spatial information.
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